Quoin Pharmaceuticals, Ltd.QNRXNASDAQ
Loading
Operating Expenses Over TimeStable
Percentile Rank67
3Y CAGR+16.3%
5Y CAGR+43.6%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+16.3%/yr
vs -12.0%/yr prior
5Y CAGR
+43.6%/yr
Recent deceleration
Acceleration
+28.2pp
Accelerating
Percentile
P67
Within normal range
vs 5Y Ago
6.1x
Strong expansion
Streak
5 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $9.53M | +1.6% |
| 2023 | $9.38M | +1.3% |
| 2022 | $9.26M | +52.7% |
| 2021 | $6.06M | +263.0% |
| 2020 | $1.67M | +7.0% |
| 2019 | $1.56M | -90.4% |
| 2018 | $16.22M | +60.7% |
| 2017 | $10.10M | -37.8% |
| 2016 | $16.22M | +528.8% |
| 2015 | $2.58M | - |